SCHEMBL17100754

SCHEMBL17100754

CCOC(=O)c1noc(N2CCNCC2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAT P00750 1/20 0.42
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
ALDH1A1 P00352 1/20 0.41
ADORA3 P0DMS8 1/20 0.39
POLB P06746 1/20 0.39
MAPK13 O15264 1/20 0.39
MAPK12 P53778 1/20 0.39
MAPK11 Q15759 1/20 0.39
MAPK14 Q16539 1/20 0.39
SLC26A6 Q9BXS9 1/20 0.37
DYRK1A Q13627 1/20 0.36
HTR2C P28335 1/20 0.36
OPRK1 P41145 1/20 0.35
MMP2 P08253 1/20 0.35
BMP1 P13497 1/20 0.35
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31706122 0.85 L3MBTL1 (0.48) NPC1LMNAMAPTHTTALDH1A1
SCHEMBL20595431 0.75 ADORA3 (0.43) NPC1MAPTALDH1A1ADORA3POLB
SCHEMBL14722740 0.73 GPR119 (0.40) NPC1LMNAMAPTHTTMMP2
SCHEMBL15763577 0.72 CHRNB2 (0.45) MAPTALDH1A1ADORA3MAPK13MAPK12
SCHEMBL18603151 0.72 KMT2A (0.54) NPC1LMNAMAPTHTTALDH1A1
SCHEMBL10996668 0.71 ALDH1A1 (0.44) LMNAMAPTHTTALDH1A1ADORA3
SCHEMBL8825216 0.71 CYP1A2 (0.43) NPC1LMNAMAPTHTTALDH1A1
SCHEMBL11518939 0.71 HRH1 (0.39) ALDH1A1SMN1; SMN2
SCHEMBL18624609 0.70 HTR6 (0.36) PLATALDH1A1HTR2CSMN1; SMN2
Hydrochloric Acid SCHEMBL14991074 0.70 HRH1 (0.38) LMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200140400-A1 OXADIAZOLE COMPOUNDS REMYND NV (BE) 2020-05-07 US disclosed
US-10562869-B2 Oxadiazole compounds REMYND NV (BE) 2020-02-18 US disclosed
US-20170073319-A1 OXADIAZOLE COMPOUNDS REMYND NV (BE) 2017-03-16 US disclosed
EP-3119774-A1 OXADIAZOLE COMPOUNDS reMynd NV (BE) 2017-01-25 EP disclosed
WO-2015140130-A1 OXADIAZOLE COMPOUNDS REMYND NV (BE) 2015-09-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10562869-B2 Oxadiazole compounds OXA1L, PSEN1, MAPT PLAT 3797/4885NPC1 1192/4885LMNA 760/4885
US-20200140400-A1 OXADIAZOLE COMPOUNDS OXA1L, PSEN1, MAPT PLAT 3770/4885NPC1 1323/4885LMNA 748/4885
US-20170073319-A1 OXADIAZOLE COMPOUNDS OXA1L, PSEN1, MAPT PLAT 3797/4885NPC1 1192/4885LMNA 760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.